A share price of Alx Oncology Holdings Inc [ALXO] is currently trading at $0.63, up 18.97%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ALXO shares have gain 30.42% over the last week, with a monthly amount glided 38.31%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alx Oncology Holdings Inc [NASDAQ: ALXO] stock has seen the most recent analyst activity on March 06, 2025, when Jefferies upgraded its rating to a Buy and also boosted its price target to $3 from $2. Previously, Jefferies downgraded its rating to Hold on December 19, 2024, and dropped its price target to $2. On March 08, 2024, downgrade downgraded it’s rating to Hold and revised its price target to $14 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $18 on December 08, 2023. Jefferies downgraded its rating to a Hold and reduced its price target to $25 on December 22, 2021. Stifel started tracking with a Buy rating for this stock on September 30, 2021, and assigned it a price target of $106.
Alx Oncology Holdings Inc experienced fluctuations in its stock price throughout the past year between $0.40 and $6.38. Currently, Wall Street analysts expect the stock to reach $1.5 within the next 12 months. Alx Oncology Holdings Inc [NASDAQ: ALXO] shares were valued at $0.63 at the most recent close of the market. An investor can expect a potential return of 138.1% based on the average ALXO price forecast.
Analyzing the ALXO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.08, Equity is -1.04 and Total Capital is -1.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5579 points at the first support level, and at 0.4897 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6651, and for the 2nd resistance point, it is at 0.7041.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Alx Oncology Holdings Inc [NASDAQ:ALXO] is 5.47. Also, the Quick Ratio is 5.47, while the Cash Ratio stands at 1.1.
Transactions by insiders
Recent insider trading involved Pinto Shelly, SVP, FINANCE AND CAO, that happened on Jul 07 ’25 when 2011.0 shares were sold. SVP, FINANCE AND CAO, Pinto Shelly completed a deal on Jun 30 ’25 to sell 1532.0 shares. Meanwhile, SVP, FINANCE AND CAO Pinto Shelly sold 550.0 shares on Feb 19 ’25.
